Prognostic factors in cancer of unknown primary site

被引:15
|
作者
Jose Fernandez-Cotarelo, Maria [1 ]
Manuel Guerra-Vales, Juan [2 ]
Colina, Francisco [3 ]
de la Cruz, Javier [4 ]
机构
[1] Hosp Mostoles, Dept Internal Med, Madrid 28935, Spain
[2] Univ Hosp 12 Octubre, CIBERESP, Dept Internal Med, Madrid, Spain
[3] Univ Hosp 12 Octubre, CIBERESP, Dept Pathol, Madrid, Spain
[4] Univ Hosp 12 Octubre, CIBERESP, Clin Epidemiol Unit, Madrid, Spain
来源
TUMORI JOURNAL | 2010年 / 96卷 / 01期
关键词
tumor metastasis; unknown primary tumors; survival; prognosis; SERUM-ALBUMIN LEVELS; PRIMARY-CARCINOMA; LIVER METASTASIS; PRIMARY ORIGIN; PRIMARY TUMORS; SURVIVAL; MANAGEMENT; MARKERS; MODEL; EXPERIENCE;
D O I
10.1177/030089161009600118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Patients with cancer of an unknown primary site (CUP) usually have a poor outcome. The identification of prognostic factors that affect survival can help clinicians find a better approach to such cases in terms of diagnostic and therapeutic management. Methods. We conducted a retrospective study including the cases of CUP recorded at the University Hospital 12 de Octubre Tumor Registry between 1999 and 2003. Results. CUP was diagnosed in 265 patients during the analyzed period. One hundred and seventy-one were men (64.5%) and the mean age of the patients was 66.9 years (range 32-98 years). The median survival was 2.5 months, and the survival rate was 35.1% 6 months from diagnosis (95% CI: 28.9-41.3) and 24.5% 1 year from diagnosis (95% CI:.18.7-30.3). Univariate analysis revealed as significant predictive variables of a better outcome age under 70 years; involvement of a single organ; normal serum levels of alkaline phosphatase and albumin; normal erythrocyte sedimentation rate; normal levels of the serum tumor markers CEA, CA 19.9 and CA 15.3; squamous carcinoma histology; clinical presentation as lymph node enlargement; and the administration of treatment. Multivariate analysis showed that albumin and alkaline phosphatase levels, squamous carcinoma histology, age and treatment were the most important prognostic factors. Other variables analyzed (liver, bone or lung involvement, lactate dehydrogenase levels, gender) did not affect survival. Conclusions. CUP has a poor prognosis. Some prognostic factors that affect survival in these patients, however, may be identified. Free full text available at www.turnorionline.it
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [31] Prognostic factors in patients with unknown primary neoplasms
    Gundersen, S
    Holthe, H
    Bruland, OS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 287 - 287
  • [32] Risk factors for cancer registry-notified cancer of unknown primary site (CUP)
    Vajdic, Claire M.
    Perez-Concha, Oscar
    Rhee, Joel
    Dobbins, Timothy
    Ward, Robyn
    Schaffer, Andrea
    van Leeuwen, Marina
    Laaksonen, Maarit
    Craigen, Glynis
    Pearson, Sallie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 84 - 85
  • [33] Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site)
    Yang, HongLiang
    He, Feng
    Xu, Wen
    Cao, Zeng
    BMC CANCER, 2022, 22 (01)
  • [34] Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site)
    HongLiang Yang
    Feng He
    Wen Xu
    Zeng Cao
    BMC Cancer, 22
  • [35] Dermatomyositis associated with cancer of unknown primary site
    Kim, Hyung Il
    Chung, Sung Hoon
    Hwang, Jun Eul
    Kim, Sang Ho
    Ahn, Jae Sook
    Yang, Duk Hwan
    Kim, Yoe Kyeoung
    Yun, Sook Jung
    Cho, Sang Hee
    Lee, JeJung
    Chung, Ik Joo
    Kim, Hyeoung Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 : S174 - S177
  • [36] Diagnostic approach to cancer of unknown primary site
    Fernandez Cotarelo, M. J.
    Guerra Vales, J. M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (07): : 347 - 351
  • [37] Inflammation as a validated prognostic determinant in carcinoma of unknown primary site
    Mohamed, Z.
    Pinato, D. J.
    Mauri, F. A.
    Chen, K-W
    Chang, P. M-H
    Sharma, R.
    BRITISH JOURNAL OF CANCER, 2014, 110 (01) : 208 - 213
  • [38] Management of patients with cancer of unknown primary site
    Weinlander, G
    Scheithauer, W
    ONKOLOGIE, 1998, 21 (01): : 67 - 71
  • [39] Management of patients with cancer of unknown primary site
    Hainsworth, JD
    Greco, FA
    ONCOLOGY-NEW YORK, 2000, 14 (04): : 563 - +
  • [40] Radiotherapeutic concepts in cancer of unknown primary site
    Krug, D.
    Debus, J.
    Sterzing, F.
    RADIOLOGE, 2014, 54 (02): : 145 - 150